S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Biden’s $374B Giveaway Into This Sector (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
How Biden has already won 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
1970’s computer coder issues shocking A.I. warning (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:KMPH

Zevra Therapeutics (KMPH) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free KMPH Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$4.48
▼
$6.27
52-Week Range
N/A
Volume
64,100 shs
Average Volume
189,500 shs
Market Capitalization
$200.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
KMPH stock logo

About Zevra Therapeutics Stock (NASDAQ:KMPH)

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses on the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

KMPH Stock News Headlines

March 4, 2024 | marketwatch.com
Zevra Therapeutics Shares Fall After FDA Extends Arimoclomol Review
February 20, 2024 | yahoo.com
Brisbane, Australia - Weather Forecasts | Maps | News - Yahoo Weather
April 18, 2024 | Paradigm Press (Ad)
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
February 17, 2024 | yahoo.com
Christchurch, New Zealand - Weather Forecasts | Maps | News - Yahoo Weather
January 11, 2024 | yahoo.com
Greater Bendigo, Australia - Weather Forecasts | Maps | News - Yahoo Weather
January 9, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Zevra Therapeutics Amid Positive Regulatory Developments and Strong Market Positioning
January 8, 2024 | markets.businessinsider.com
Zevra Therapeutics Says FDA Accepts Resubmission Of Arimoclomol NDA In Niemann-Pick Disease Type C
January 6, 2024 | yahoo.com
Wellington, New Zealand - Weather Forecasts | Maps | News - Yahoo Weather
April 18, 2024 | Paradigm Press (Ad)
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.
December 27, 2023 | msn.com
Zevra seeks FDA nod for rare disease therapy arimoclomol
December 27, 2023 | marketwatch.com
Zevra Therapeutics Refiles Arimoclomol Application With FDA
December 23, 2023 | yahoo.com
Queenstown, New Zealand - Weather Forecasts | Maps | News - Yahoo Weather
December 11, 2023 | yahoo.com
Melbourne, Australia - Weather Forecasts | Maps | News - Yahoo Weather
December 11, 2023 | yahoo.com
Oroquieta City, Philippines - Weather Forecasts | Maps | News - Yahoo Weather
December 1, 2023 | yahoo.com
Tehran, Iran - Weather Forecasts | Maps | News - Yahoo Weather
November 9, 2023 | markets.businessinsider.com
Zevra Therapeutics: Promising Growth Avenues and Potential Approvals Bolster Buy Rating
October 26, 2023 | yahoo.com
Phnom Penh, Cambodia - Weather Forecasts | Maps | News - Yahoo Weather
August 26, 2023 | yahoo.com
Nowra, Australia - Weather Forecasts | Maps | News - Yahoo Weather
August 26, 2023 | yahoo.com
Temuka, New Zealand - Weather Forecasts | Maps | News - Yahoo Weather
August 14, 2023 | seekingalpha.com
Zevra Therapeutics GAAP EPS of -$0.15 beats by $0.19, revenue of $8.5M beats by $5.47M
July 30, 2023 | yahoo.com
Manama, Bahrain - Weather Forecasts | Maps | News - Yahoo Weather
July 29, 2023 | yahoo.com
Kanayannur, India - Weather Forecasts | Maps | News - Yahoo Weather
July 29, 2023 | yahoo.com
Monte-Carlo, Monaco - Weather Forecasts | Maps | News - Yahoo Weather
July 27, 2023 | yahoo.com
Geneva, Switzerland - Weather Forecasts | Maps | News - Yahoo Weather
July 27, 2023 | yahoo.com
Bellevue, United States - Weather Forecasts | Maps | News - Yahoo Weather
July 25, 2023 | yahoo.com
Nairobi, Kenya - Weather Forecasts | Maps | News - Yahoo Weather
July 25, 2023 | yahoo.com
Munich, Germany - Weather Forecasts | Maps | News - Yahoo Weather
See More Headlines
Receive KMPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/30/2022
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:KMPH
CUSIP
N/A
CIK
1434647
Web
www.kempharm.com
Phone
(321) 939-3416
Fax
319-665-2577
Employees
22
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,560,000.00
Net Margins
-328.56%
Pretax Margin
-335.26%
Return on Equity
-16.12%
Return on Assets
-14.17%

Debt

Debt-to-Equity Ratio
0.14
Current Ratio
10.10
Quick Ratio
10.10

Sales & Book Value

Annual Sales
$10.72 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
23.28
Book Value
$3.63 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
34,505,000
Free Float
34,125,000
Market Cap
$200.47 million
Optionable
Optionable
Beta
2.16
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

KMPH Stock Analysis - Frequently Asked Questions

How were Zevra Therapeutics' earnings last quarter?

Zevra Therapeutics, Inc. (NASDAQ:KMPH) issued its earnings results on Wednesday, March, 30th. The specialty pharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.08). Zevra Therapeutics had a negative net margin of 328.56% and a negative trailing twelve-month return on equity of 16.12%.

What other stocks do shareholders of Zevra Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zevra Therapeutics investors own include Sorrento Therapeutics (SRNE), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX), AVEO Pharmaceuticals (AVEO), Aldeyra Therapeutics (ALDX), Exelixis (EXEL), BioCryst Pharmaceuticals (BCRX), Cara Therapeutics (CARA), DURECT (DRRX) and Paratek Pharmaceuticals (PRTK).

When did Zevra Therapeutics IPO?

Zevra Therapeutics (KMPH) raised $60 million in an initial public offering on Thursday, April 16th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and RBC Capital Markets served as the underwriters for the IPO and Canaccord Genuity and Oppenheimer were co-managers.

This page (NASDAQ:KMPH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company